Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Vaccines and immunotherapy in hematological malignancies

David Avigan • 8 Sep 2020
SOHO 2020
General CAR-T

David E. Avigan, MD, Beth Israel Deaconess Medical Center and Dana-Farber/Harvard Cancer Center, Boston, MA, discusses the use of vaccines and immunotherapy in hematological malignancies, including the presentation of multiple antigens on a platform of dendritic cell co-stimulation, as well as the importance of understanding the tumor microenvironment. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from David Avigan

Overcoming challenges in TCR mapping for personalized immunotherapy in multiple myeloma
1:09
Overcoming challenges in TCR mapping for personalized immunotherapy in multiple myeloma
David Avigan • 23 Sep 2026
Identifying tumor-reactive T-cell clones to guide personalized immunotherapy in multiple myeloma
1:25
Identifying tumor-reactive T-cell clones to guide personalized immunotherapy in multiple myeloma
David Avigan • 23 Sep 2026
Single-cell antigen & TCR mapping to investigate tumor-reactive T-cell responses in multiple myeloma
3:08
Single-cell antigen & TCR mapping to investigate tumor-reactive T-cell responses in multiple myeloma
David Avigan • 23 Sep 2026
Impact of dendritic cell fusion vaccine on the microenvironment and outcomes in multiple myeloma
2:26
Impact of dendritic cell fusion vaccine on the microenvironment and outcomes in multiple myeloma
David Avigan • 26 Aug 2022

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals